{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:44:41Z","timestamp":1793641481746,"version":"4.5.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2016-02349"],"award-info":[{"award-number":["2016-02349"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2020-01998"],"award-info":[{"award-number":["2020-01998"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006636","name":"Forskningsr\u00e5det om H\u00e4lsa, Arbetsliv och V\u00e4lf\u00e4rd","doi-asserted-by":"publisher","award":["2015-00195"],"award-info":[{"award-number":["2015-00195"]}],"id":[{"id":"10.13039\/501100006636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006636","name":"Forskningsr\u00e5det om H\u00e4lsa, Arbetsliv och V\u00e4lf\u00e4rd","doi-asserted-by":"publisher","award":["2019-00697"],"award-info":[{"award-number":["2019-00697"]}],"id":[{"id":"10.13039\/501100006636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Swedish Brain Foundation","doi-asserted-by":"crossref","award":["FO2020-0077"],"award-info":[{"award-number":["FO2020-0077"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003792","name":"Swedish Brain Foundation","doi-asserted-by":"crossref","award":["FO2024-0344"],"award-info":[{"award-number":["FO2024-0344"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100018163","name":"Margareta af Ugglas Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018163","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018367","name":"Swedish Foundation for MS Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018367","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Neuro Sweden"},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multiple sclerosis (MS) is a heterogeneous disease with highly variable long-term outcomes. We aimed to identify patterns of disability progression and their determinants to improve individualized risk assessment and support clinical decision-making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We applied latent class trajectory modeling to Expanded Disability Status Scale (EDSS) data from 3163 newly diagnosed relapsing-onset MS cases in the Swedish Epidemiological Investigation of MS (2005\u20132019). Baseline demographics, clinical, and lifestyle data were collected at diagnosis, and participants were followed through the Swedish MS registry. Multivariate logistic regression was used to examine associations between baseline characteristics and trajectory group membership. Kaplan\u2013Meier analysis estimated time to confirmed disability worsening, EDSS 3 and EDSS 4 across trajectory groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seven distinct EDSS trajectories were identified. Group 4 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091149) was the most common and characterized by stable, low disability. Groups 5\u20137 showed steadily increasing disability and were categorized as unfavorable (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009662). In multivariate models, older age at diagnosis, longer baseline disease duration, higher baseline EDSS score, more frequent early relapses, poor cognitive performance, and autoimmune comorbidities were associated with unfavorable progression. Among lifestyle factors, obesity, smoking, and low sun exposure were linked to worse outcomes, while high physical activity decreased the odds of unfavorable progression. No significant association was observed for baseline vitamin D levels. Time to confirmed disability progression outcomes differed substantially across trajectory groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Early clinical and lifestyle factors were associated with long-term outcomes. These findings illustrate the heterogeneity of MS progression and support further investigation of early modifiable factors influencing long-term outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00415-026-13704-5","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T03:03:47Z","timestamp":1771643027000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Disability progression in multiple sclerosis: a latent class analysis of predictors"],"prefix":"10.1007","volume":"273","author":[{"given":"Jie","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Alfredsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6612-4749","authenticated-orcid":false,"given":"Anna Karin","family":"Hedstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,21]]},"reference":[{"key":"13704_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi M, Bar-Or A, Piehl F et al (2018) Multiple sclerosis. Nat Rev Dis Primers 4:43","journal-title":"Nat Rev Dis Primers"},{"key":"13704_CR2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41586-023-06250-x","volume":"619","author":"A Harroud","year":"2023","unstructured":"Harroud A, Stridh P, McCauley JL et al (2023) Locus for severity implicates CNS resilience in progression of multiple sclerosis. Nature 619:323\u2013311","journal-title":"Nature"},{"key":"13704_CR3","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1093\/brain\/awq118","volume":"133","author":"A Scalfari","year":"2010","unstructured":"Scalfari A, Neuhaus A, Degenhardt A et al (2010) The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability. Brain 133:1914\u20131929","journal-title":"Brain"},{"key":"13704_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/B978-0-444-52001-2.00014-5","volume":"122","author":"C Confavreux","year":"2014","unstructured":"Confavreux C, Vukusic S (2014) The clinical course of multiple sclerosis. Handb Clin Neurol 122:343\u2013369","journal-title":"Handb Clin Neurol"},{"key":"13704_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-025-08142-6","author":"Y Huang","year":"2025","unstructured":"Huang Y (2025) Predictive factors for the progression of multiple sclerosis: a meta-analysis. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-025-08142-6. ((Online ahead of print))","journal-title":"Neurol Sci"},{"key":"13704_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122686","volume":"10","author":"KA Ribbons","year":"2015","unstructured":"Ribbons KA, McElduff P, Boz C et al (2015) Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS. PLoS ONE 10:e122686","journal-title":"PLoS ONE"},{"key":"13704_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2024.123161","volume":"464","author":"R Gouider","year":"2024","unstructured":"Gouider R, Souissi A, Mrabet S et al (2024) Environmental factors related to multiple sclerosis progression. J Neurol Sci 464:123161","journal-title":"J Neurol Sci"},{"key":"13704_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16269","volume":"31","author":"J Wu","year":"2024","unstructured":"Wu J, Olsson T, Alfredsson L et al (2024) Association between sun exposure habits and disease progression in multiple sclerosis. Eur J Neurol 31:e16269","journal-title":"Eur J Neurol"},{"key":"13704_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2024-335200","author":"E Johansson","year":"2025","unstructured":"Johansson E, Guo J, Wu J et al (2025) Impact of fish consumption on disability progression in multiple sclerosis. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2024-335200. ((Online ahead of print))","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13704_CR10","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1177\/1352458516675039","volume":"23","author":"A Kavaliunas","year":"2017","unstructured":"Kavaliunas A, Manouchehrinia A, Stawiarz L et al (2017) Importance of early treatment initiation in the clinical course of multiple sclerosis. Mult Scler 23:1233\u20131240","journal-title":"Mult Scler"},{"key":"13704_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S1474-4422(20)30067-3","volume":"19","author":"A He","year":"2020","unstructured":"He A, Merkel B, Brown JW et al (2020) Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study. Lancet Neurol 19:307\u2013316","journal-title":"Lancet Neurol"},{"key":"13704_CR12","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/jnnp-2024-333632","volume":"96","author":"A Zarghami","year":"2025","unstructured":"Zarghami A, Hussain MA, van der Mei I et al (2025) Long-term disability trajectories in multiple sclerosis: a group-based trajectory analysis of the AusLong cohort. J Neurol Neurosurg Psychiatry 96:424\u2013434","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13704_CR13","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman CH, Reingold SC, Edan G et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria.\u201d Ann Neurol 58:840\u2013846","journal-title":"Ann Neurol"},{"key":"13704_CR14","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald Criteria. Ann Neurol 69:292\u2013302","journal-title":"Ann Neurol"},{"key":"13704_CR15","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s10654-013-9853-4","volume":"28","author":"AK Hedstr\u00f6m","year":"2013","unstructured":"Hedstr\u00f6m AK, Hillert J, Olsson T, Alfredsson L (2013) Smoking and multiple sclerosis susceptibility. Eur J Epidemiol 28:867\u2013874","journal-title":"Eur J Epidemiol"},{"key":"13704_CR16","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s10654-025-01276-z","volume":"40","author":"P Alping","year":"2025","unstructured":"Alping P, Frisell T, He A et al (2025) Completeness and generalizability of the Swedish MS register. Eur J Epidemiol 40:905\u2013913","journal-title":"Eur J Epidemiol"},{"key":"13704_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","volume":"6","author":"DS Nagin","year":"2010","unstructured":"Nagin DS, Odgers CL (2010) Group-based trajectory modeling for clinical research. Annu Rev Clin Psychol 6:109\u2013138","journal-title":"Annu Rev Clin Psychol"},{"key":"13704_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/10705511.2014.882690","volume":"21","author":"SY Kim","year":"2014","unstructured":"Kim SY (2014) Determining the number of latent classes in single- and multi-phase growth mixture models. Struct Equ Modeling 21:263\u2013279","journal-title":"Struct Equ Modeling"},{"key":"13704_CR19","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1177\/1352458517703800","volume":"24","author":"A Signori","year":"2018","unstructured":"Signori A, Izquierdo G, Lugaresi A et al (2018) Long-term disability trajectories in primary progressive MS patients: a latent class growth analysis. Mult Scler 24:642\u2013652","journal-title":"Mult Scler"},{"key":"13704_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/jnnp-2022-329987","volume":"94","author":"A Signori","year":"2023","unstructured":"Signori A, Lorscheider J, Vukusic S et al (2023) Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network. J Neurol Neurosurg Psychiatry 94:23\u201330","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13704_CR21","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1177\/1352458516665496","volume":"23","author":"M Pitteri","year":"2017","unstructured":"Pitteri M, Romualdi C, Magliozzi R et al (2017) Cognitive impairment predicts disability progression and cortical thinning in MS: an 8-year study. Mult Scler 23:848\u2013854","journal-title":"Mult Scler"},{"key":"13704_CR22","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/ana.23591","volume":"72","author":"EM Mowry","year":"2012","unstructured":"Mowry EM, Waubant E, McCulloch CE et al (2012) Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Ann Neurol 72:234\u2013240","journal-title":"Ann Neurol"},{"key":"13704_CR23","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1001\/jamaneurol.2013.5993","volume":"71","author":"A Ascherio","year":"2014","unstructured":"Ascherio A, Munger KL, White R et al (2014) Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurol 71:306\u2013314","journal-title":"JAMA Neurol"},{"key":"13704_CR24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/jnnp-2024-334062","volume":"96","author":"A Giordano","year":"2025","unstructured":"Giordano A, Clarelli F, Pignolet B et al (2025) Vitamin D affects the risk of disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 96:170\u2013176","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13704_CR25","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1093\/brain\/awad409","volume":"147","author":"H Butzkueven","year":"2024","unstructured":"Butzkueven H, Ponsonby AL, Stein MS et al (2024) Vitamin D did not reduce multiple sclerosis disease activity after a clinical isolated syndrome. Brain 147:1206\u20131215","journal-title":"Brain"},{"key":"13704_CR26","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.3390\/nu15081945","volume":"15","author":"J Langlois","year":"2023","unstructured":"Langlois J, Denimal D (2023) Clinical and imaging outcomes after vitamin D supplementation in patients with multiple sclerosis: a systematic review. Nutrients 15:1945","journal-title":"Nutrients"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13704-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13704-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13704-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T22:04:18Z","timestamp":1773785058000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13704-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["13704"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13704-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"J. Guo reports no disclosures relevant to this manuscript; T. Olsson has received lecture\/advisory board honoraria, and unrestricted MS research grants from Biogen, Novartis, Sanofi, and Merck; L. Alfredsson has received personal fees from Teva and Biogen; A.K. Hedstr\u00f6m reports no disclosures relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"157"}}